|
Model Number RIGID SADDLE RING |
Device Problems
Material Separation (1562); Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Dyspnea (1816); Hemorrhage/Bleeding (1888); Heart Failure/Congestive Heart Failure (4446); Mitral Valve Insufficiency/ Regurgitation (4451)
|
Event Date 11/14/2022 |
Event Type
Injury
|
Event Description
|
Clinical information: crd_985 - arb pmcf, patient site id: de4432-476, r727995501.It was reported that on (b)(6) 2022, a 30mm rigid saddle ring was successfully implanted in a patient.Pre-operatively the patient was found to have unspecified degenerative mitral and tricuspid valve tissue.The patient had mitral valve leaflet repair (plication), tricuspid annuloplasty, and left atrial appendage closure all during the same surgery.On (b)(6) 2022, it was discovered via a computed tomography scan, that the patient had an intrathoracic hematoma/bleeding.The decision was made to perform a surgical evacuation/drainage of the hematoma/bleeding.There was in-patient/prolonged hospitalization due to this event.The patient's condition resolved and the patient was discharged on (b)(6) 2022.
|
|
Manufacturer Narrative
|
Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
|
|
Event Description
|
Clinical information: (b)(4), patient site id: (b)(6).Subsequent to the previously filed report , additional information was received that there had been no difficulty experienced implanting the 30mm rigid saddle ring.On (b)(6) 2022, it was noted via transesophageal echocardiogram that dehiscence of the 30mm rigid saddle ring had occurred due to a cardiac tear.Grade 3 mitral valve insufficiency/regurgitation was also noted via transesophageal echocardiogram and resulted in cardiac decompensation, dyspnea, and a new york heart association (nyha) functional class of 3-4.The decision was made successfully to explant the 30mm rigid saddle ring and replace it with a 33mm epic valve.The patient was stable at the time of report.The cardiac tear was due to frailty/weakness of the cardiac tissue.The mitral valve insufficiency/regurgitation was due to the ring dehiscence.There is no allegation of malfunction against the 30mm rigid saddle ring or procedure.
|
|
Manufacturer Narrative
|
An event of hematoma/bleeding, insufficiency/regurgitation ,cardiac tear, cardiac decompensation and explant of ring due to dehiscence was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met specifications.Information from the field indicated that it is believed that the hematoma/bleeding was caused by the disorder morbus olser, which the patient was previously diagnosed with.The cardiac tear was due to frailty/weakness of the cardiac tissue.The field also added that the regurgitation was caused by ring dehiscence.There was no allegation made against the device.Based on the information received, the cause of the reported incident could not be conclusively determined but could have been as a result of the procedure exacerbating the patient's medical condition pre-procedure.There is no indication of a product quality issue with regards to manufacture, design, or labeling.H6 medical device problem code: code 2993 removed.
|
|
Search Alerts/Recalls
|
|
|